CN110256528B - 一种能够显著清除活性氧(ros)的天然寡肽 - Google Patents
一种能够显著清除活性氧(ros)的天然寡肽 Download PDFInfo
- Publication number
- CN110256528B CN110256528B CN201910605671.3A CN201910605671A CN110256528B CN 110256528 B CN110256528 B CN 110256528B CN 201910605671 A CN201910605671 A CN 201910605671A CN 110256528 B CN110256528 B CN 110256528B
- Authority
- CN
- China
- Prior art keywords
- oligopeptide
- natural
- natural oligopeptide
- ros
- mobile phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010038807 Oligopeptides Proteins 0.000 title claims abstract description 71
- 102000015636 Oligopeptides Human genes 0.000 title claims abstract description 71
- 239000003642 reactive oxygen metabolite Substances 0.000 title abstract description 39
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 37
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 37
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 35
- 241000220215 Moringa Species 0.000 claims abstract description 34
- 230000000694 effects Effects 0.000 claims abstract description 31
- 102000016938 Catalase Human genes 0.000 claims abstract description 16
- 108010053835 Catalase Proteins 0.000 claims abstract description 16
- 102000019197 Superoxide Dismutase Human genes 0.000 claims abstract description 16
- 108010012715 Superoxide dismutase Proteins 0.000 claims abstract description 16
- 108010007119 flavourzyme Proteins 0.000 claims abstract description 14
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 4
- FGGPAWQCCGEWTJ-UHFFFAOYSA-M sodium;2,3-bis(sulfanyl)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(S)CS FGGPAWQCCGEWTJ-UHFFFAOYSA-M 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 12
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 12
- 239000003531 protein hydrolysate Substances 0.000 claims description 12
- 238000000108 ultra-filtration Methods 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 238000004007 reversed phase HPLC Methods 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 8
- 230000003834 intracellular effect Effects 0.000 claims description 7
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 7
- 239000012498 ultrapure water Substances 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 6
- 238000001641 gel filtration chromatography Methods 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 6
- 229960000281 trometamol Drugs 0.000 claims description 6
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 claims description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 claims description 5
- KGNSGRRALVIRGR-QWRGUYRKSA-N Gln-Tyr Chemical group NC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KGNSGRRALVIRGR-QWRGUYRKSA-N 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000005571 anion exchange chromatography Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 31
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 14
- 230000002209 hydrophobic effect Effects 0.000 abstract description 12
- 150000002632 lipids Chemical class 0.000 abstract description 11
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 238000006388 chemical passivation reaction Methods 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 5
- 230000004888 barrier function Effects 0.000 abstract description 3
- 230000002950 deficient Effects 0.000 abstract description 3
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 3
- 229930195729 fatty acid Natural products 0.000 abstract description 3
- 239000000194 fatty acid Substances 0.000 abstract description 3
- 150000004665 fatty acids Chemical class 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 20
- 230000003078 antioxidant effect Effects 0.000 description 19
- 239000000243 solution Substances 0.000 description 18
- 238000006460 hydrolysis reaction Methods 0.000 description 13
- 101800000068 Antioxidant peptide Proteins 0.000 description 12
- 230000007062 hydrolysis Effects 0.000 description 12
- 150000003254 radicals Chemical class 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 10
- 239000003963 antioxidant agent Substances 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000003859 lipid peroxidation Effects 0.000 description 9
- 229920001184 polypeptide Polymers 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 8
- -1 hydroxyl radicals Chemical class 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 239000012488 sample solution Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 5
- 230000017854 proteolysis Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 239000000413 hydrolysate Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 230000009920 chelation Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- ASJCVVGLGXVRGQ-UHFFFAOYSA-N 1-butyl-2-methoxybenzene Chemical compound CCCCC1=CC=CC=C1OC ASJCVVGLGXVRGQ-UHFFFAOYSA-N 0.000 description 1
- VFNKZQNIXUFLBC-UHFFFAOYSA-N 2',7'-dichlorofluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Cl)=C(O)C=C1OC1=C2C=C(Cl)C(O)=C1 VFNKZQNIXUFLBC-UHFFFAOYSA-N 0.000 description 1
- FEXBEKLLSUWSIM-UHFFFAOYSA-N 2-Butyl-4-methylphenol Chemical group CCCCC1=CC(C)=CC=C1O FEXBEKLLSUWSIM-UHFFFAOYSA-N 0.000 description 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000252185 Cobitidae Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 229910021577 Iron(II) chloride Inorganic materials 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 244000179886 Moringa oleifera Species 0.000 description 1
- 241000220214 Moringaceae Species 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- 241000075387 Thamnaconus septentrionalis Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001437 electrospray ionisation time-of-flight quadrupole detection Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000009920 food preservation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000037041 intracellular level Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 230000000990 untiurolithic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910605671.3A CN110256528B (zh) | 2019-07-05 | 2019-07-05 | 一种能够显著清除活性氧(ros)的天然寡肽 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910605671.3A CN110256528B (zh) | 2019-07-05 | 2019-07-05 | 一种能够显著清除活性氧(ros)的天然寡肽 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110256528A CN110256528A (zh) | 2019-09-20 |
CN110256528B true CN110256528B (zh) | 2021-08-10 |
Family
ID=67924679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910605671.3A Active CN110256528B (zh) | 2019-07-05 | 2019-07-05 | 一种能够显著清除活性氧(ros)的天然寡肽 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110256528B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116445460B (zh) * | 2023-04-18 | 2023-11-21 | 陕西科技大学 | 一种降血压和抗氧化肽粉制备及其在奶粉中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104788541A (zh) * | 2015-05-07 | 2015-07-22 | 南京财经大学 | 具有抗氧化活性的小肽、制备方法及其应用 |
CN108889110A (zh) * | 2018-08-08 | 2018-11-27 | 中国恩菲工程技术有限公司 | 烟气的除汞方法 |
CN109486889A (zh) * | 2018-12-29 | 2019-03-19 | 武汉天天好生物制品有限公司 | 一种辣木籽小分子多肽及其制备工艺 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102697706A (zh) * | 2012-04-17 | 2012-10-03 | 上海禾丰制药有限公司 | 二巯丙磺钠注射液、胶囊及其制备方法 |
-
2019
- 2019-07-05 CN CN201910605671.3A patent/CN110256528B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104788541A (zh) * | 2015-05-07 | 2015-07-22 | 南京财经大学 | 具有抗氧化活性的小肽、制备方法及其应用 |
CN108889110A (zh) * | 2018-08-08 | 2018-11-27 | 中国恩菲工程技术有限公司 | 烟气的除汞方法 |
CN109486889A (zh) * | 2018-12-29 | 2019-03-19 | 武汉天天好生物制品有限公司 | 一种辣木籽小分子多肽及其制备工艺 |
Non-Patent Citations (2)
Title |
---|
Li-li Liang等.Purification of antioxidant peptides of Moringa oleifera seeds and their protective effects on H2O2 oxidative damaged Chang liver cells.《Journal of Functional Foods》.2019, * |
Mark Williams.CHEBI:141432 - Gln-Tyr.《ChEBI数据库》.2018, * |
Also Published As
Publication number | Publication date |
---|---|
CN110256528A (zh) | 2019-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhou et al. | Antioxidant peptides isolated from sea cucumber Stichopus Japonicus | |
Yu et al. | Purification and identification of antioxidant peptides from enzymatic hydrolysate of Spirulina platensis | |
CN111647072B (zh) | 一种抗氧化肽及其制备方法和应用 | |
KR101729209B1 (ko) | 미선나무 추출물의 항산화 효과를 활용한 스킨케어 제품 조성물 | |
KR20070073873A (ko) | 플루케네티아 볼루빌리스 속에 속하는 식물의 추출물 및그의 미용 용도 | |
CN110606872B (zh) | 一种促皮肤创伤修复的抗氧化多肽oa-gl17及其制备方法与应用 | |
CN116514912B (zh) | 抗皮肤氧化损伤的草菇多肽及其应用 | |
CN110240630A (zh) | 一种具有肝细胞氧化损伤保护作用的天然寡肽 | |
Jung et al. | Free radical scavenging activity of a novel antioxidative peptide isolated from in vitro gastrointestinal digests of Mytilus coruscus | |
CN110256528B (zh) | 一种能够显著清除活性氧(ros)的天然寡肽 | |
Jeampakdee et al. | The apoptotic and free radical–scavenging abilities of the protein hydrolysate obtained from chicken feather meal | |
Ma et al. | Identification of novel antioxidant peptides from sea squirt (Halocynthia roretzi) and its neuroprotective effect in 6-OHDA-induced neurotoxicity | |
CN110283230B (zh) | 一种抗氧化肽及其应用 | |
KR101512064B1 (ko) | 알러지 성분이 제거된 분리정제봉독을 이용한 기능성 봉독 화장품 조성물의 제조방법 | |
CN110256529B (zh) | 一种抗氧化肽及其应用 | |
KR101305136B1 (ko) | 캔디다 루고펠리쿨로사에 의해 발효된, 항산화 활성을 갖는 해양 미세조류 파블로바 루테리, 그로부터 유래된 펩타이드 및 이를 함유하는 항산화 기능성 건강식품용 조성물 | |
CN113528605B (zh) | 一种超声辅助酶解制备单环刺螠内脏抗氧化肽的方法 | |
KR100207807B1 (ko) | 항산화성 펩티드 및 그의 생산방법 | |
He et al. | Components and Antioxidant Activity of the Polysaccharide from Streptomyces virginia H03 | |
Kim et al. | Fractionation and characterization of fractions with high antioxidative activity from the gelatin hydrolysates of Korean rockfish Sebastes schlegelii skin | |
CN110256530B (zh) | 一种抗氧化肽及其应用 | |
KR101224809B1 (ko) | 레티노산 유도체, 이의 제조 방법 및 이를 포함하는 화장품 조성물 | |
Wang et al. | Antioxidant properties of marine macroalgae | |
KR101822043B1 (ko) | 블루 로터스 및 아이슬란드 이끼의 복합 추출물을 유효성분으로 포함하는 화장료 조성물 | |
CN116284229B (zh) | 一种抗氧化珍珠贝活性肽及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221028 Address after: 710000 No. B49, Xinda Zhongchuang space, 26th Street, block C, No. 2 Trading Plaza, South China City, international port district, Xi'an, Shaanxi Province Patentee after: Xi'an Huaqi Zhongxin Technology Development Co.,Ltd. Address before: 316100 plot C2-10, Xiaohui Industrial Zone, Putuo exhibition, Putuo marine science and Technology Industrial Park, Putuo District, Zhoushan City, Zhejiang Province Patentee before: Zhejiang Ocean University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231024 Address after: 271000 first road, electromechanical Industrial Park, Shandong Daiyue Economic Development Zone, Tai'an City, Shandong Province Patentee after: Shandong Jusheng Biotechnology Co.,Ltd. Address before: 710000 No. B49, Xinda Zhongchuang space, 26th Street, block C, No. 2 Trading Plaza, South China City, international port district, Xi'an, Shaanxi Province Patentee before: Xi'an Huaqi Zhongxin Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right |